Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Leucémies chroniques
- | Specialty :
- Chimiothérapie
- Thérapies Ciblées
Extract
Phase III randomized trial to evaluate the efficacy and safety of second-line therapy with fludara plus alemtuzumab (campath, mabcampath) versus fludara alone in patients with B-cell chronic lymphocytic leukemia.
Scientific Abstract
en cours d'intégration;